Revocation of Methods of Analysis Regulation
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Feb. 19, 2026. Document 2026-03285. Updated Nov. 14, 2026.
- What it does
The Food and Drug Administration (FDA, the Agency, or we) is issuing a final rule to revoke the methods of analysis regulation, which describes an FDA policy to use certain methods of analysis for FDA enforcement programs when the method of analysis is not prescribed in a regulation. FDA is issuing this action because the existing regulation is no longer necessary.
The Food and Drug Administration's summary, as published in the Federal Register.
- What changed in the regulation
1 part of Title 21 of the Code of Federal Regulations:
Wording on eCFR: the day before it took effect and from the day it took effect (first part listed).
- Compared with
The Food and Drug Administration has published 103 final rules in 2026 so far, compared with 68 in all of 2025.
Counted by the Tribune from Federal Register records since Jan. 1, 2025.
- Before this
No earlier Federal Register document under regulation identifier 0910-AI65 since Jan. 1, 2025.
- What happens next and when
This rule is effective on March 23, 2026.
The agency's dates, word for word.
The record as published
| Document number | 2026-03285 |
|---|---|
| Action | Final rule. |
| Agencies | Health and Human Services Department; Food and Drug Administration |
| Published | Feb. 19, 2026 |
| Effective date | March 23, 2026 |
| Regulation identifier (RIN) | 0910-AI65 |
| Docket | FDA-2020-N-1383 |
Source: the Federal Register (public domain). The document in the Federal Register